- Report
- May 2023
- 134 Pages
Global
From €2400EUR$2,499USD£2,066GBP
- Report
- October 2023
- 173 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- August 2023
- 150 Pages
Global
From €4082EUR$4,250USD£3,514GBP
- Report
- January 2021
- 545 Pages
Global
From €4754EUR$4,950USD£4,093GBP
- Report
- March 2023
- 375 Pages
Global
From €11526EUR$12,000USD£9,923GBP
- Report
- June 2020
- 111 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- June 2018
Europe
From €8639EUR$8,995USD£7,438GBP
- Report
- November 2021
- 120 Pages
Global
From €4322EUR$4,500USD£3,721GBP
The Reverse Shoulder Arthroplasty (RSA) market is a segment of the Orthopedic Devices industry. RSA is a surgical procedure used to treat shoulder joint problems, such as rotator cuff tears, shoulder fractures, and shoulder arthritis. It involves replacing the shoulder joint with an artificial joint, which is composed of a metal ball and a plastic socket. The procedure is used to restore shoulder function and reduce pain.
RSA is a relatively new procedure, and the market is still in its early stages. However, it is growing rapidly due to its effectiveness in treating shoulder joint problems. The market is expected to benefit from the increasing prevalence of shoulder joint problems, as well as the growing demand for minimally invasive procedures.
The RSA market is highly competitive, with several major players. These include Zimmer Biomet, Stryker, Smith & Nephew, and DePuy Synthes. These companies are investing heavily in research and development to develop new products and technologies to improve the effectiveness of the procedure. Show Less Read more